FDA approves Teva’s austedo to treat chorea in HD patients

This article was originally published here

Teva Pharmaceutical has secured approval from the US Food and Drug Administration (FDA) for austedo (deutetrabenazine) tablets to treat chorea associated with Huntington’s disease (HD).

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply